• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烯丙基硫氰酸酯类作为一类新型抗结核药物。

Allylic thiocyanates as a new class of antitubercular agents.

机构信息

Departamento de Química, Instituto de Química, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.

出版信息

Bioorg Med Chem Lett. 2012 Oct 15;22(20):6486-9. doi: 10.1016/j.bmcl.2012.08.048. Epub 2012 Aug 21.

DOI:10.1016/j.bmcl.2012.08.048
PMID:22967767
Abstract

TB is a global public health emergency in which new drugs are desperately needed. Herein we report on the synthesis of a diverse panel of 41 aryl allylic azides, thiocyanates, isothiouronium salts, and N,N'-diacetylisothioureas that were evaluated for their in vitro activity against replicating and non-replicating Mycobacterium tuberculosis (Mtb) H(37)Rv and toxicity to VERO cells. We found a selective group of new and promising compounds having good (micromolar) to excellent (sub-micromolar) potency against replicating Mtb H(37)Rv. Allylic thiocyanates bearing halophenyl (halo=2-Br, 4-Br, 4-Cl, 4-F), 4-methylphenyl and 2-naphthyl moieties were the most active as antitubercular agents. In particular, the 2-bromophenyl-substituted thiocyanate showed MIC=0.25 μM against replicating Mtb, MIC=8.0 μM against non-replicating Mtb and IC(50)=32 μM in the VERO cellular toxicity assay.

摘要

结核病是一种全球公共卫生紧急情况,急需新的药物。在此,我们报告了合成了一组多样化的 41 种芳基烯丙基叠氮化物、硫氰酸盐、异硫脲盐和 N,N'-二乙酰基异硫脲,评估了它们对复制和非复制结核分枝杆菌(Mtb)H(37)Rv 的体外活性和对 VERO 细胞的毒性。我们发现了一组新的有希望的化合物,它们对复制的 Mtb H(37)Rv 具有良好(微摩尔级)至优异(亚微摩尔级)的活性。带有卤代苯基(卤代=2-Br、4-Br、4-Cl、4-F)、4-甲基苯基和 2-萘基部分的烯丙基硫氰酸盐是最有效的抗结核药物。特别是,2-溴代苯基取代的硫氰酸盐对复制的 Mtb 的 MIC=0.25 μM,对非复制的 Mtb 的 MIC=8.0 μM,在 VERO 细胞毒性测定中的 IC(50)=32 μM。

相似文献

1
Allylic thiocyanates as a new class of antitubercular agents.烯丙基硫氰酸酯类作为一类新型抗结核药物。
Bioorg Med Chem Lett. 2012 Oct 15;22(20):6486-9. doi: 10.1016/j.bmcl.2012.08.048. Epub 2012 Aug 21.
2
6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.抗结核分枝杆菌复制和非复制状态的 6-氢-8-甲基喹诺酮。
Chem Biol Drug Des. 2012 Nov;80(5):781-6. doi: 10.1111/cbdd.12022. Epub 2012 Sep 10.
3
Novel dihydropyrimidines as a potential new class of antitubercular agents.新型二氢嘧啶类化合物:一种有潜力的新型抗结核药物。
Bioorg Med Chem Lett. 2010 Oct 15;20(20):6100-2. doi: 10.1016/j.bmcl.2010.08.046. Epub 2010 Aug 14.
4
Structural requirements for the antitubercular quaternized triflupromazine pharmacophore.抗结核季铵化三氟丙嗪药效团的结构要求。
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5679-80. doi: 10.1016/j.bmcl.2012.06.095. Epub 2012 Jul 6.
5
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.新型吡唑类似物作为结核分枝杆菌抑制剂的合成、生物学评价及构效关系研究:第2部分。刚性吡唑啉酮的合成。
Bioorg Med Chem. 2009 Aug 1;17(15):5716-21. doi: 10.1016/j.bmc.2009.05.058. Epub 2009 May 29.
6
Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.N-取代2-氨基噻唑衍生物作为抗结核药物的设计、合成及构效关系研究
Eur J Med Chem. 2014 Jan 24;72:26-34. doi: 10.1016/j.ejmech.2013.11.007. Epub 2013 Nov 13.
7
Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.8-羟基喹啉杀死非复制分枝杆菌。
J Antimicrob Chemother. 2010 Jul;65(7):1424-7. doi: 10.1093/jac/dkq145. Epub 2010 Apr 30.
8
Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.一系列对复制型和非复制型结核分枝杆菌具有活性的喹啉类化合物的构效关系。
J Med Chem. 2009 Apr 9;52(7):2109-18. doi: 10.1021/jm900003c.
9
Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.四氢吲唑类配体的鉴定、合成及作为新型抗结核药物的药理评价。
J Med Chem. 2010 Jan 28;53(2):649-59. doi: 10.1021/jm901235p.
10
Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.合成及取代嘧啶并[5,4-d]嘧啶类化合物的体外评价作为新型抗结核分枝杆菌药物。
Eur J Med Chem. 2010 Jul;45(7):3234-9. doi: 10.1016/j.ejmech.2010.03.047. Epub 2010 Apr 3.

引用本文的文献

1
Design, synthesis, and evaluation of novel 2-substituted 1,4-benzenediol library as antimicrobial agents against clinically relevant pathogens.新型2-取代1,4-苯二酚文库作为抗临床相关病原体抗菌剂的设计、合成与评价
Saudi Pharm J. 2019 Dec;27(8):1064-1074. doi: 10.1016/j.jsps.2019.09.003. Epub 2019 Sep 25.
2
Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents.优化和评价 5-取代基-氧杂噻唑-2-酮结核分枝杆菌蛋白酶体抑制剂作为潜在抗结核药物。
ChemistryOpen. 2015 Jun;4(3):342-62. doi: 10.1002/open.201500001. Epub 2015 Apr 17.
3
Antimicrobial activity of allylic thiocyanates derived from the Morita-Baylis-Hillman reaction.
源自森田-贝利斯-希尔曼反应的烯丙基硫氰酸盐的抗菌活性。
Braz J Microbiol. 2014 Oct 9;45(3):807-12. doi: 10.1590/s1517-83822014000300007. eCollection 2014.